Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU

Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU

Score another pre-approval sale for coronavirus vaccine-maker Moderna (NASDAQ: MRNA). European Commission President Ursula von der Leyen has announced that the EC will ink a deal with the company on Wednesday. The contract will allow the European Union's member countries to purchase up to 160 million doses of Moderna's COVID-19 vaccine, mRNA-1273, once the vaccine is approved by EU regulators.